U.S., June 23 -- ClinicalTrials.gov registry received information related to the study (NCT07661251) titled 'ITTACA (Immunotherapy Time Teller for Advanced Lung Cancer)' on Jan. 23.
Brief Summary: Immunotherapy is a relatively new treatment that uses patients' own immune systems to fight diseases, particularly cancers.
Recent studies suggest that the effectiveness of immunotherapy in cancer treatment may depend on the time of day it is given.
This observational study wants to explore this further by looking at the effectiveness of immunotherapy in lung cancer patients in relation to their circadian rhythms. A circadian rhythm is the body's natural internal clock that regulates sleep, wakefulness, hormones, temperature and other bodily fu...